Magzter GOLDで無制限に

Magzter GOLDで無制限に

9,500以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Intas Pharma bags another overseas company

Mint Hyderabad

|

January 08, 2025

Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

- Sreeja Biswas

Intas Pharma has agreed to buy the Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.

Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.

Mint Hyderabad からのその他のストーリー

Mint Hyderabad

When street dogs, cats bring the office closer

When colleagues work towards a collective goal like looking after community animals, it offers them a sense of purpose

time to read

4 mins

September 15, 2025

Mint Hyderabad

US, Chinese officials hold talks in Spain

US and Chinese officials began talks in Madrid on Sunday on their strained trade ties, a looming divestiture deadline for Chinese short video app TikTok and Washington's demands that its allies place tariffs on China over its purchases of Russian oil.

time to read

1 min

September 15, 2025

Mint Hyderabad

Will We Disprove Yes Minister With Pension Reforms?

In Yes Minister, a TV satire on British politics, Sir Humphrey often stymied urgent reforms by setting up ‘interdepartmental committees.’

time to read

3 mins

September 15, 2025

Mint Hyderabad

It's Clear That Gamblers Should Pay More Taxes Than Investors

Investing aids the economy but gambling is simply consumption

time to read

3 mins

September 15, 2025

Mint Hyderabad

Q-comm gaming the grocery run

Platforms are leaning on gamification for marketing & retention

time to read

2 mins

September 15, 2025

Mint Hyderabad

Why Meme Marketers Hate Congratulations

With more budgets moving to influencer and meme marketing, it's sometimes hard to tell what is an ad and what isn't

time to read

4 mins

September 15, 2025

Mint Hyderabad

SonyLIV rolls with duel despite outrage

The broadcaster, streaming Asia Cup for first time, is sure of adding viewers, boosting revenue despite Indo-Pak tensions

time to read

2 mins

September 15, 2025

Mint Hyderabad

Govt alert on Cairo pharma payments

The Indian embassy in Cairo has issued a cautionary trade advisory to all Indian pharmaceutical exporters regarding Biomed For Pharmaceutical Industries, an Egyptian firm.

time to read

1 min

September 15, 2025

Mint Hyderabad

Digital loans against MFs are fast, but here's what you should know

Do not max out the LTV ratio, do not use it for long-term funding, and keep a watch on market volatility

time to read

5 mins

September 15, 2025

Mint Hyderabad

To curb smokeless tobacco use, India targets 100 high-burden districts

Consumption of smokeless tobacco, a leading cause for cancer, remains one of India's biggest public health challenges, with more than one in five people using such products.

time to read

2 mins

September 15, 2025

Listen

Translate

Share

-
+

Change font size